Peter Oppelt

Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff et al. · Clinical Cancer Research · 2020 · 365 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden et al. · The Lancet Oncology · 2021 · 258 citations · Full text

Medicine, Oncology, Cancer Pharmacology +10

The VCUAM (Vagina Cervix Uterus Adnex–associated Malformation) Classification: a new classification for genital malformations

Peter Oppelt, D. Wallwiener, Matthias W. Beckmann · Fertility and Sterility · 2005 · 249 citations · Full text

Medicine, Gynecology, Obstetrics +9

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

Alain G. Zeimet, Daniel Reimer, Monica Huszar et al. · JNCI Journal of the National Cancer Institute · 2013 · 233 citations

Medicine, Oncology, Pathology +17

The rASRM score and the Enzian classification for endometriosis: their strengths and weaknesses

Dietmar Haas, Omar Shebl, Andreas Shamiyeh et al. · Acta Obstetricia Et Gynecologica Scandinavica · 2012 · 200 citations · Full text

Medicine, Gynecology, Pathology +12